Everything tagged "ipo" across the TickerSpark archives.
Tarsier Pharma Ltd. (NYSE: TARX) is expected to list on 2026-07-09, with 5,000,000 shares priced at $8.00 to $10.00 each. The company is a late-stage ophthalmic biotech with no product revenue yet, so the setup hinges on clinical progress rather than current sales.
IQM Quantum Computers Oyj American Depositary Shares is expected to list on NASDAQ on 2026-07-02, but the price range has not been disclosed. The deal is a SPAC merger with Real Asset Acquisition Corp. under ticker IQMX. Bull case: a real systems-delivery track record; bear case: quantum remains early, loss-making, and execution-heavy.
Vicore Pharma Holding AB American Depositary Shares are expected to list on NASDAQ on 2026-07-02, with the price range not disclosed yet. This is a U.S. dual listing, not a traditional cash-raising IPO, so the main question is whether the story around buloxibutid is strong enough to attract U.S. investors. The bull case is a first-in-class IPF drug in a large unmet market; the bear case is a clinical-stage company still years from commercialization.
Aeon Acquisition I Corp. Rights (NASDAQ: AESPR) is expected to list on 2026-07-01, but the price range has not been disclosed yet. This is a SPAC, so the story is about sponsor execution and deal-finding, not operating growth. The setup favors investors who want a rights-heavy blank-check structure, but the key question is whether the team can source a credible merger target.
ITG, Inc. Class A Common Stock is expected to list on NASDAQ on 2026-07-01, but the price range has not been disclosed yet. The company is offering 19,512,196 shares. The setup leans on fiber and digital infrastructure demand, but investors should watch leverage, margin pressure, and customer spending risk as pricing comes into view.
Neutron Holdings Inc. (NASDAQ: LIME) is expected to list on 2026-07-01 at a $24.00-$26.00 price range. The company is offering 6,956,522 shares, with the deal sized around a $208 million market cap if disclosed terms hold. The bull case is Lime’s growth and scale; the bear case is regulation, losses, and a business that still depends on city permits.
Idaho Copper Corporation (NYSE, expected 2026-07-01) has not disclosed its price range yet. The company is expected to list on the NYSE as COPR, with terms still pending. The bull case is a large Idaho copper-molybdenum-silver project tied to electrification demand; the bear case is a pre-production developer with no revenue, a going-concern warning, and heavy dilution risk.
Luminar Technologies, Inc. (NYSE: LAZR) is expected to list on 2026-06-30, but the price range has not been disclosed. The setup pits a real LiDAR/autonomy story against persistent losses, customer-program risk, and a crowded sensor market.
Professionally Managed Portfolios - Pabrai Wagons Fund (NYSE: WAGN) is expected to list on 2026-06-30, but the price range has not been disclosed. This is not a traditional operating-company IPO; it is an ETF reorganization that will trade on the NYSE. The setup favors investors who want a concentrated industrial-transportation strategy, but shareholders should watch key-man risk and ETF trading dynamics.
Exchange Listed Funds Trust is expected to list on the NYSE on 2026-06-29, but the price range has not been disclosed. The key question is not classic IPO growth, but whether the market wants another ETF platform wrapper for new fund launches. Bull case: scalable ETF infrastructure; bear case: this is not a conventional operating-company IPO and there is no disclosed pricing yet.
AmperCap Acquisition Company Right (NASDAQ: APMCR) is expected to list on 2026-06-29, but the price range has not been disclosed yet. This is a SPAC, so the key question is not operating growth — it is whether the sponsor can source a credible deal and keep the shares near trust value. Bull case: the team has cross-border M&A experience and a U.S.-Mexico focus. Bear case: no target has been announced, and SPAC dilution and deadline risk remain the main story.
StablecoinX Inc. Class A Common Stock is expected to list on NASDAQ on 2026-06-26 under the symbol USDE, but the price range has not been disclosed. The deal is a SPAC business combination, not a traditional operating-company IPO. The bull case is early exposure to the Ethena ecosystem; the bear case is a tiny revenue base and heavy execution risk.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime